KCK is a family investment fund that invests in a diverse set of industries, including medical technologies. KCK interests in Life Sciences - Biopharm/ Biotech & MedTech, Energy, Science-rich companies and Industrial Technologies. KCK invest at all stages of a startup's from early stage to growth rounds and also invest in public companies. KCK is the private equity arm of a family office which seeks to partner with experienced management teams, focused on niche markets, deploying long-term flexible capital to generate high risk-adjusted returns.